LEXICON PHARMACEUTICALS, INC. (LXRX) Operating margin 2017–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-98.2%FY2025 · since FY2017: -822.1% → -98.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -98.2% | +3186.5 pp |
| FY2024 | -3284.7% | +12188.2 pp |
| FY2023 | -15473.0% | — |
| FY2020 | -204.2% | -641.7 pp |
| FY2019 | 437.5% | +826.0 pp |
| FY2018 | -388.5% | +433.5 pp |
| FY2017 | -822.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net incomeLXRX Net marginLXRX Gross profitLXRX Gross marginLXRX Operating incomeLXRX Operating cash flowLXRX Free cash flowLXRX Capital expendituresLXRX Return on equityLXRX Stock buybacksLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →